Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06192823 · ClinicalTrials.gov registry record
Feasibility Of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's Disease
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT06192823 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT06192823 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the feasibility of adding objective measures (FDG-PET imaging, wearable biosensors) to a week-long washout protocol in early-stage Parkinson's disease patients. This study is also determining whether the washout can be conducted in the ambulatory setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2025-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06192823
The ClinicalTrials.gov registry entry for NCT06192823 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06192823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06192823 about?
NCT06192823 is a clinical study titled "Feasibility Of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's Disease". This study will evaluate the feasibility of adding objective measures (FDG-PET imaging, wearable biosensors) to a week-long washout protocol in early-stage Parkinson's disease patients. This study is also determining whether the washout can be conducted in the ambulatory setting.
What is the current status of trial NCT06192823?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-03-22. Estimated completion is 2025-02-18.
Who is sponsoring clinical trial NCT06192823?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.